StockWatch
·
Pharmaceuticals
Board Meeting14 Nov 2026, 08:24 pm

Gufic Biosciences Board Approves Unaudited Financial Results, Appoints Director

AI Summary

Gufic Biosciences Ltd announced the outcome of its Board of Directors meeting held on November 14, 2026. The board considered and approved the unaudited financial results (standalone and consolidated) for the Quarter and Half Year ended September 30, 2026, along with the limited review report. Additionally, Dr. Reeta Shah was appointed as an Additional Director (Non-Executive Independent Director) for a term of 5 years, effective December 01, 2026, subject to shareholder approval. The meeting commenced at 5:00 p.m. and concluded at 06:35 p.m.

Key Highlights

  • Board approved unaudited financial results for Q2 and H1 FY27.
  • Limited review report on financial results also approved.
  • Dr. Reeta Shah appointed as Additional Director (Non-Executive Independent).
  • Appointment is for 5 years, effective December 01, 2026.
  • Shareholder approval is required for the directorship.